SHARP THERAPEUTICS CORP (SHRX.CA) Stock Cash Flow
Canada - TSX-V:SHRX - CA8200092077 - Common Stock
3.24 CAD
-0.38 (-10.5%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -5.76M | -3.26M | -184.60K | -27.90K | -13.50K | |||
| Depreciation Amortization | N/A | 100.30K | N/A | N/A | N/A | |||
| Change In Working Capital | -79.70K | 60.10K | -15.60K | 23.50K | 13.50K | |||
| Other non cash items | N/A | -515.10K | 22.90K | N/A | N/A | |||
| OPERATING CASH FLOW | -6.16M | -3.62M | -124.60K | 3.60K | 0.00 | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -14.50K | N/A | N/A | N/A | |||
| Other Investing Activity | N/A | 5.10K | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | N/A | -9.40K | N/A | N/A | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 1.76M | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | N/A | 4.96M | 300.20K | 57.40K | N/A | |||
| Other Financing Activity | N/A | N/A | 0.00 | -10.70K | 79.60K | |||
| FINANCING CASH FLOW | N/A | 6.73M | 300.20K | 46.70K | 79.60K | |||
| Exchange Rate Effect | N/A | 6.10K | N/A | N/A | N/A | |||
| CHANGE IN CASH | 2.96M | 3.11M | 175.70K | 50.30K | 79.50K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -6.16M | -3.62M | -124.60K | 3.60K | 0.00 | |||
| Capital Expenditure | N/A | -14.50K | N/A | N/A | N/A | |||
| FREE CASH FLOW | -6.18M | -3.63M | -124.60K | 3.60K | 0.00 | |||
All data in USD